Esqueda-Suárez JL

Idioma: Español
Referencias bibliográficas: 4
Paginas: 42-44
Archivo PDF: 454.88 Kb.

FRAGMENTO

Sin Resumen.

REFERENCIAS (EN ESTE ARTÍCULO)

1. Rehsia S, Shayegan B. PSA implications and medical management of prostate cancer for the primary care physician. Can J Urol. 2012 Oct;19(5 Suppl 1):28-35.

2. Nakatani H, Kumon T, Kumon M, Hamada S, Okanoue T, Kawamura A, et al. High serum levels of both carcinoembryonic antigen and carbohydrate antigen 19-9 in a patient with sigmoid colon cancer without metastasis. J Med Invest. 2012;59(3-4):280-3.

3. 3.Steffensen KD, Waldstrøm M, Brandslund I, Petzold M, Jakobsen A. The Prognostic and Predictive Value of Combined HE4 and CA-125 in Ovarian Cancer Patients. Int J Gynecol Cancer. 2012 Nov;22(9):1474-82.

4. Thomakos N, Rodolakis A, Zagouri F, Zacharakis D, Sotiropoulou M, Akrivos N, et al. Serum CA 125, CA 15-3, CEA, and CA 19-9: a prognostic factor for uterine carcinosarcomas? Arch Gynecol Obstet. 2012 Sep 1. [Epub ahead of print]